Euronext Brussels

Belgian indices

BEL 20 5,500.30 -0.89 %
BEL ALL-SHARE 18,304.44 -0.25 %
BEL MID INDEX 6,439.01 -0.68 %
BEL SMALL INDEX 7,991.37 -1.04 %
BEL CONTINUOUS 48,392.46 -0.25 %

EU indices

EURONEXT 100 1,854.41 -0.46 %
CLIMATE EUROPE 2,333.24 -0.52 %
LOW CARBON 100 175.28 -0.77 %
NEXT BIOTECH 3,857.62 +0.96 %
ESG 80 2,207.29 -1.31 %

Currency rates - Last and change

EUR / USD 1.15986 -0.30 %
EUR / GBP 0.86401 +0.02 %
EUR / JPY 185.6045 -0.22 %
EUR / CHF 0.91815 +0.30 %
GBP / USD 1.34246 -0.29 %

Top performers Brussels

Loading... Please wait.
Belgian indices
BEL 20
Chart
BEL ALL-SHARE
Chart
BEL CONTINUOUS
Chart
BEL MID INDEX
Chart
BEL SMALL INDEX
Chart
Company news
03 Jun 2026
18:00 CEST
Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026
03 Jun 2026
18:00 CEST
Disclosure of transparency notification from FMR LLC
03 Jun 2026
18:00 CEST
Openbaarmaking van transparantiekennisgeving van FMR LLC
03 Jun 2026
18:00 CEST
Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 1 juni 2026
03 Jun 2026
17:55 CEST
Nextensa announces the reservation of 196 residential units at Bel Towers by Vicinity              
03 Jun 2026
17:55 CEST
Nextensa kondigt de reservatie aan van 196 woningen in Bel Towers door Vicinity
03 Jun 2026
17:55 CEST
Nextensa annonce la réservation de 196 logements à Bel Towers par Vicinity
03 Jun 2026
17:40 CEST
DEME secures dredging contract to enhance access to strategic Tunisian ports
03 Jun 2026
17:40 CEST
DEME haalt baggercontract binnen om toegang tot strategische Tunesische havens te verbeteren
03 Jun 2026
17:40 CEST
Agfa-Gevaert meldt wijzigingen in de Raad van Bestuur
03 Jun 2026
17:40 CEST
Agfa-Gevaert announces changes to the Board of Directors
03 Jun 2026
08:45 CEST
Syensqo - Participation notification by BlackRock Inc.
03 Jun 2026
07:45 CEST
Azelis: Transparency Notifications From UBS Group AG
03 Jun 2026
07:45 CEST
Azelis: Transparantiekennisgevingen UBS Group AG
03 Jun 2026
07:00 CEST
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at…
02 Jun 2026
18:00 CEST
Oxurion étend ses compétences pour répondre à la demande croissante de services de recherche clinique dédiés aux GLP-1…
02 Jun 2026
18:00 CEST
Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services
02 Jun 2026
08:31 CEST
Programme de rachats d'actions
02 Jun 2026
08:29 CEST
Share buyback programme
02 Jun 2026
08:00 CEST
Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the…
IPOs
MATERIALISE
ADEC INNOVATIONS
ENERGYVISION
SYENSQO
DMS IMAGING
More Euronext Brussels

Learn more about our Brussels markets

Visit our Brussels page on Euronext.com and learn about the home to the BEL20. 

Euronext Brussels - Le Marquis